[{"Assets_0_Q2_USD":"67984000000.0","CIK":"882095","CommonStockDividendsPerShareDeclared_1_Q2_USD":"0.71","CommonStockDividendsPerShareDeclared_2_Q2_USD":"1.42","CommonStockSharesIssued_0_Q2_shares":"1254000000.0","CommonStockSharesOutstanding_0_Q2_shares":"1254000000.0","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"1.21","EarningsPerShareBasic_2_Q2_USD":"2.59","EarningsPerShareDiluted_1_Q2_USD":"1.21","EarningsPerShareDiluted_2_Q2_USD":"2.58","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"78838305412.0","MinorityInterest_0_Q2_USD":"7000000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"4926000000.0","NetIncomeLoss_1_Q2_USD":"1522000000.0","NetIncomeLoss_2_Q2_USD":"3251000000.0","OfficialName":"Gilead Sciences Inc. Common Stock","PaymentsOfDividends_2_Q2_USD":"1811000000.0","ProfitLoss_1_Q2_USD":"1517000000.0","ProfitLoss_2_Q2_USD":"3239000000.0","RevenuesConverted_1_Q2_USD":"6217000000.0","RevenuesConverted_2_Q2_USD":"12640000000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":"19710000000.0","StockholdersEquity_0_Q2_USD":"19703000000.0","Ticker":"GILD","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"1260000000.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"1261000000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"1255000000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"1256000000.0","filed":"20210805","footnote":null,"form":"10-Q","fp":"Q2","fy":"2021.0","name":"GILEAD SCIENCES INC","period":"20210630","qtrs":"0","uom":"USD"}]